Is there a link between inflammatory bowel disease and the metabolic syndrome? Hester Franks Academic F2 Supervisors Professors Hawkey and Macdonald.

Slides:

Advertisements

Similar presentations

Inflammatory Bowel Disease: Overview

Advertisements

IBD Ulcerative Colitis Crohn’s Disease. IBD  Pathogenesis – genetics +environment (smoking,infection,drugs)  UC –bloody diarrhoea. Exacerbation & remission-50%/yr.

Positional Cloning LOD Sib pairs Chromosome Region Association Study Genetics Genomics Physical Mapping/ Sequencing Candidate Gene Selection/ Polymorphism.

An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation Barrette Kathleen – Dreesen Erwin Asseman.

Dalia Munoz.  Its an inflammatory bowel disease (IBD) that causes a long- lasting inflammation in your digestive tract.

By: Boris Eng and Dominic Moscarello Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Disease Francisco A. Sylvester, MD Associate Professor of Pediatrics.

 Asthma  Allergens  Rheumatoid Arthritis  Inflammatory Bowel Disease  Crohn’s disease  Ulcerative Colitis.

CLINICAL AND ENDOSCOPIC CORRELATION OF INFLAMMATORY BOWEL DISEASE Coordinator: Prof. Univ. Dr. Simona Băţagă Students: Andra Oltean Stoica Ioan Adrian.

Community Medicine V Dr. Mehrdad Askarian MD, MPH Professor of Community Medicine.

소화기내과 R1. 임형석 / Pf. 김정욱. BACKGROUND Recent data showed that H. pylori infection is less common in patients with IBD The prevalence of IBD has been increasing.

1 Yize R. Wang, MD, PhD, John R. Cangemi, MD, Edward V. Loftus Jr, MD and Michael F. Picco, MD, PhD Am J Gastroenterol 2013;108:444–449 F1 김혁 / Prof. 김효종.

GUT 2012;61:1533–1537. R4 Kim Dong Hyun / Fellow Kim Jung Wook Higher Predicted Vitamin D Status Is Associated With Reduced Risk of Crohn’s Disease.

Brendan Burke and Kyle Steffen. Important New Tool in Genomic Medicine GWAS is used to estimate disease risk and test SNPs( the most common type of genetic.

(*BMI ≥30, or ~ 30 lbs. overweight for 5’ 4” person) No Data

Inflammatory Bowel Disease Is Associated With an Increased Incidence of Cardiovascular Events Andres J. Yarur, MD, Amar R. Deshpande, MD, David M. Pechman,

R3. 최태웅 / Pf. 김효종 Alimentary Pharmacology & Therapeutics 19 FEB 2016 DOI: /apt.13547

The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States Michael D. Kappelman, Sheryl L. Rifas–Shiman,

Ulcerative colitis andTrichuris infection

Clinical Gastroenterology and Hepatology

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Work disability in inflammatory bowel disease

Inflammatory Bowel Disease (IBD) is a Risk Factor for Extrahepatic Cholangiocarcinoma (ECC) in Subjects Without Underlying Primary Sclerosing Cholangitis.

The Nurse’s Role in Inflammatory Bowel Disease

WHO ARE WE The IMAGINE Network is investigating the interactions between inflammation, microbiome, diet and mental health in patients with inflammatory.

Ulcerative Colitis (UC)-Associated Colorectal Cancer (CRC) Patients Who Receives Colorectal Surgery More Likely Receive Blood Transfusion Than Crohn’s.

Indeterminate and inconclusive results are common when using Interferon Gamma Release Assay as screening for TB in patients with IBD Nasr I, Goel RM, Ward.

Conclusion and Acknowledgement

WHO ARE WE The IMAGINE Network is investigating the interactions between inflammation, microbiome, diet and mental health in patients with inflammatory.

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

YouTube® and inflammatory bowel disease

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD) Mariam Aguas, Vicente Garrigues,

Clinical Nutrition University: Nutrition in the prevention and management of irritable bowel syndrome, constipation and diverticulosis Eduard Cabré

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

Expression and functional analysis of intestinal organic cation/l-carnitine transporter (OCTN) in Crohn's Disease Marc Girardin, Serge Dionne, Philippe.

Medical management of inflammatory bowel disease

1 Patient enrollment flow chart.

Serum prohepcidin levels in chronic inflammatory bowel diseases

Mersin University TURKEY

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

Get Here is the best Treatment for Ulcerative Colitis

Reply Gastroenterology

Volume 136, Issue 2, Pages (February 2009)

Volume 147, Issue 4, Pages e7 (October 2014)

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Osteoporosis in inflammatory bowel disease

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

Volume 134, Issue 7, Pages (June 2008)

Obesity Trends* Among U.S. Adults BRFSS, 1990, 2000, 2010

Reply Gastroenterology

Volume 152, Issue 1, Pages (January 2017)

Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors Anilga Moradkhani, Linda.

In Vitro Fertilization in Women With Inflammatory Bowel Disease Is as Successful as in Women From the General Infertility Population Sveta Shah Oza,

Individual patients’ FCP (μg/g) values (n=119).

Inflammatory Bowel Disease Is Associated With Poor Outcomes of Patients With Primary Sclerosing Cholangitis Jing Hieng Ngu, Richard Blair Gearry, Andrew.

Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta

Eligibility criteria for inclusion as an expert Delphi panellist

Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Siddharth.

Rectal Mucosal Nitric Oxide in Differentiation of Inflammatory Bowel Disease and Irritable Bowel Syndrome Claudia I. Reinders, Max Herulf, Tryggve Ljung,

Volume 115, Issue 4, Pages (October 1998)

Meenakshi Bewtra, Chinyu Su, James D. Lewis

This Month in Gastroenterology

Inflammatory Bowel Disease in African American Children Compared With Other Racial/Ethnic Groups in a Multicenter Registry Jolanda M. White, Siobhán.

David S. Fefferman, Richard J. Farrell

The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States Michael D. Kappelman, Sheryl L. Rifas–Shiman,

Risk factors for postoperative infection after lower gastrointestinal surgery in patients with inflammatory bowel disease: Findings from a large epidemiological.

Cox regression analysis of the proportion of patients remaining in remission during azathioprine treatment related to diagnosis of inflammatory bowel disease.

Cox regression analysis of the proportion of patients remaining in remission after stopping azathioprine treatment related to diagnosis of inflammatory.

Trivedi C, Shah Y, Khan N Slides compiled by Dr. Michael Stewart

Presentation transcript:

Is there a link between inflammatory bowel disease and the metabolic syndrome? Hester Franks Academic F2 Supervisors Professors Hawkey and Macdonald

Background and hypothesis Methods Results to date

Background and hypothesis Inflammatory bowel disease (IBD) Crohns disease (CD) Ulcerative colitis (UC) Metabolic syndrome Genetic predisposition to both conditions There seem to be an increasing number of obese patients in IBD clinics. Is it possible that in the obese patients it is their obesity/the metabolic syndrome rather than these polymorphisms which predisposes them to IBD?

Methods 3 groups CD BMI>28 CD BMI<23 Controls BMI>28 2 parts to study Genetic analysis for SNPs & baseline metabolic analysis Detailed analysis of fasting and postprandial metabolic state

Results So far 167 UC patients 110 CD patients Healthy volunteers being recruited by advertisement No gene/metabolic data yet

BMI distributions of UC and CD

Conclusions to date There does seem to be an overweight subgroup in CD +/- UC SNP analysis may give us evidence that some of the overweight patients have IBD as a manifestation of the metabolic syndrome